Myeloid Angiogenic Cells Act as Alternative M2 Macrophages and Modulate Angiogenesis through Interleukin-8

Endothelial progenitor cells (EPCs) promote angiogenesis, and clinical trials have shown such cell therapy to be feasible for treating ischemic disease. However, clinical outcomes have been contradictory owing to the diverse range of EPC types used. We recently characterized two EPC subtypes, and id...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Medina, Reinhold J, O’Neill, Christina L, O’Doherty, T Michelle, Knott, Henry, Guduric-Fuchs, Jasenka, Gardiner, Tom A, Stitt, Alan W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: ScholarOne 2011
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188859/
https://ncbi.nlm.nih.gov/pubmed/21670847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00129
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia